ArticleApplied biochemistry and biotechnology2026
Collagen Peptide Infused Biphasic Gel Formulation for Burn Wound Management: Biophysical, Pharmacokinetic, and In Vivo Evaluation.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although herbal and bioactive wound dressings are known to promote healing, integrated dressings combining both agents for burn wounds have not been reported. The present study describes the development of a novel herbal biphasic gel (bigel) uniquely combining fish-derived bioactive collagen peptides with phytochemical rich Aloe vera and virgin coconut oil addressing critical limitations of conventional hydrogels and organogels. Among the five formulations, F4 (80:20) hydrogel: organogel (v/v) demonstrated optimal pH, stability and spreadability. It also demonstrated sustained collagen peptide release (97.7%, p < 0.0001) over 18 h following diffusion-controlled kinetics. In vitro studies confirmed its exceptional biocompatibility, demonstrating 100% cell viability, minimal hemolysis (4–6%), excellent antioxidant activity and significant cell migration (91.39% ± 1.95%, p < 0.0001) at 1 mg/ml within 12 h. In vivo studies on male albino Wistar rats with deep partial-thickness burns showed substantial wound healing, with F4-treated wounds reducing to 0.3 cm (p < 0.0001) by day 30, compared to 0.8 cm (p < 0.0001) with Silverex® (positive control) and 1.5 cm in untreated control. Histopathological analysis further supported these findings, revealing enhanced skin regeneration characterized by extensive collagen deposition, new blood vessel formation, and hair follicle development. These findings establish F4 bigel as a paradigm shift towards cost-effective, sustainable, and effective topical therapy for burn wound healing.
Indexed as
Identifiers
41817944What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.